GL1X · GenesisL1 explorer

Research workbench

Crystal structure of oxa-405 beta-lactamase

Analyse Crystal structure of oxa-405 beta-lactamase in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5FDH
Type
protein
Length
484 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
A0A0F6P2I5
Ligands
SO4
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-lactamase (EC 3.5.2.6)protein24240% helix, 21% strandA0A0F6P2I5

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 12 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13810.710.8364SO4
22420.620.8138empty
3680.310.7418SO4, GOL

Interfaces

1 interface between chains.

  • A–B · 1025 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (carboxylation).

Compared structures

  • 5FDH · Crystal structure of oxa-405 beta-lactamase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.